Novel Therapeutic Approaches for Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration DOI Creative Commons
Deokho Lee, Soo Jin Kim, Junyeop Lee

et al.

Vision, Journal Year: 2025, Volume and Issue: 9(2), P. 35 - 35

Published: April 17, 2025

Retina, a light-sensitive layer of tissue the eye, requires high levels oxygen for its physiology. Retinal ischemia occurs due to inadequate supply blood retina and choroid. is implicated in development or progression many ocular diseases, such as diabetic retinopathy (DR) age-related macular degeneration (AMD). To date, anti-vascular endothelial growth factor (VEGF) treatment has been widely used manage neovascular diseases associated with retinal ischemia. Nonetheless, substantial number patients DR AMD still suffer from incomplete response adverse effects related therapy limitations. Therefore, research scientists have developing finding novel treatments protect against prevent vision loss those diseases. In this review article, we summarize recent therapeutic approaches ischemic (e.g., cell therapy, advanced molecular targeting, drug delivery). This summary enables further obtain more solid evidence effective

Language: Английский

Advances in Regenerative Medicine, Cell Therapy, and 3D Bioprinting for Glaucoma and Retinal Diseases DOI
Kevin Y. Wu, Rahma M Osman,

Obinna Esomchukwu

et al.

Advances in experimental medicine and biology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

1
Novel Therapeutic Approaches for Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration DOI Creative Commons
Deokho Lee, Soo Jin Kim, Junyeop Lee

et al.

Vision, Journal Year: 2025, Volume and Issue: 9(2), P. 35 - 35

Published: April 17, 2025

Retina, a light-sensitive layer of tissue the eye, requires high levels oxygen for its physiology. Retinal ischemia occurs due to inadequate supply blood retina and choroid. is implicated in development or progression many ocular diseases, such as diabetic retinopathy (DR) age-related macular degeneration (AMD). To date, anti-vascular endothelial growth factor (VEGF) treatment has been widely used manage neovascular diseases associated with retinal ischemia. Nonetheless, substantial number patients DR AMD still suffer from incomplete response adverse effects related therapy limitations. Therefore, research scientists have developing finding novel treatments protect against prevent vision loss those diseases. In this review article, we summarize recent therapeutic approaches ischemic (e.g., cell therapy, advanced molecular targeting, drug delivery). This summary enables further obtain more solid evidence effective

Language: Английский

Citations

0